Health
Cellid, IVI sign research service contract to evaluate immunogenicity of COVID-19 vaccine – News-Medical.Net
Cellid and the International Vaccine Institute have exchanged a collaborative research agreement to analyze the immunogenicity of the COVID-19 vaccine “AdCLD-CoV19″….
Cellid and the International Vaccine Institute (IVI) have exchanged a collaborative research agreement to analyze the immunogenicity of the COVID-19 vaccine “AdCLD-CoV19”.
Cellid and IVI announced on January 4 that they have signed a research service contract to cooperate in the clinical development of the “AdCLD-CoV19”, a COVID-19 vaccine being developed by Cellid.
Under this contract, IVI will analyze samples from Phase 1/2a clinical trials of Cellid’s COVID-19 vaccine “AdCLD-CoV19” to determine…
-
Noosa News16 hours agoMan allegedly killed at teenage house party identified as co-founder of Universal Store
-
Noosa News21 hours agoFather found stabbed dead upstairs at teenagers’ Brisbane house party
-
Noosa News21 hours agoSA ban on plastic produce stickers on hold as growers struggle with costs
-
General21 hours agoJim Chalmers will have to juggle competing demands to secure tax reform